The global trocars market size was estimated at USD 1.45 billion in 2023 and is projected to grow at a compound annual growth rate (CAGR) of 7.10% from 2024 to 2030. Favorable reimbursement policies, growing reliance on laparoscopy, and an ageing population drive up demand for trocars in the coming years. In addition, the growing prevalence of liver and gastrointestinal illnesses has raised interest in general medical procedures, which positively impacts market growth.
In 2023, six out of ten Americans will have at least one chronic illness, such as diabetes, cancer, heart disease, and stroke, according to a report by the National Center for Chronic Disease Prevention and Health Promotion. This is the main cause of disability and death in America, along with other chronic diseases, and is also the main contributor to health care expenses. For instance, according to the Centers for Disease Control and Prevention (CDC ) estimates that 90% of the country's healthcare spending, or almost $4.1 trillion annually, is dedicated to treating mental health issues and chronic diseases.
Furthermore, most surgical procedures are performed on the geriatric population, which is more susceptible to chronic diseases like heart attack and cancer. According to the Asian Development Bank, the population of people aged 60 or more is likely to reach 1.3 billion by 2050. This population is expected to grow as the baby boomer generation ages. Therefore, it is anticipated that the industry's demand for surgical procedures will be driven by the growing geriatric population. Therefore, it is anticipated that the global market is expected to expand firmly during the forecast period due to the aforementioned factors.
Trocars are becoming more and more important in laparoscopic surgeries. Hence, the market for trocars is driven by several factors, including the number of laparoscopic surgeries performed annually and the growing popularity of minimally invasive surgeries. In addition, increasing R&D activity in the market, growing potential for growth in emerging economies, and rising technological advancements and modernization in the healthcare sector are anticipated to contribute to the market's expansion during the projected period.
There is a considerable degree of innovation in the global market; new techniques and technologies are constantly being developed and released by key players. It has grown in popularity as a disposable trocar that yields reliable and safe results. Because of this, industry participants spend more on developing cutting-edge techniques and technologies to meet the demand for products.
Several market players, such as CONMED Corporation, The Cooper Companies, Inc., Teleflex Incorporated, and Medtronic, are involved in strategic activities like partnership, M&A, and new product development to expand their geographic reach and enter new territories.
Medical devices are frequently categorized according to risk, and each class is subject to different regulations. Trocars are surgical instruments, so they might need to undergo regulatory approval to guarantee their safety and efficacy. To guarantee the uniformity and calibre of their output, manufacturers are typically obliged to establish and maintain quality management systems (QMS). Regulatory bodies frequently mandate adherence to established standards like ISO 13485.
A trocar is a medical device that consists of a cannula, a seal, and an obturator with a metal or non-bladed tip. The trocar is an entry point for various tools, including staplers, scissors, and graspers. Trocars are highly useful devices that allow gas or liquid to escape from internal organs. Although trocars are frequently used in minimally invasive surgery, some other techniques and tools can be used to accomplish the same objectives. The following are some substitutes for trocars: Blunt tip trocars, Hasson Technique, Veress Needle, and Visual Entry Systems.
The end-user concentration factor is essential for any company in the trocars industry. In this dynamic and constantly changing market, companies can position themselves for success by comprehending the specific demands of each industry and customizing their solutions accordingly.
Based on product type, the disposable trocars segment led the market with largest revenue share of 63.90% in 2023. The dominance can be attributed to its growing importance in laparoscopic surgery and diagnostic laparoscopy. During laparoscopic procedures, disposable trocars are frequently used as access ports to insert cameras into the abdominal cavity. Because they are disposable, each surgery can be set up quickly and easily while maintaining sterility, lowering the risk of infection, and requiring no reprocessing.
The reusable trocars are expected to register the fastest CAGR during the forecast period. The segment's growth is supported by factors like affordability and simplicity of access to the body's internal structure. It can result in significant cost savings over time for facilities with high procedure volumes. Using disposable trocars increases the amount of medical waste produced and raises environmental issues. Hence, healthcare facilities have preferred reusable trocars recently, driving segment growth.
Based on tip, the bladeless trocars segment held the market with largest revenue share in 2023. In upcoming years, bladeless trocars are possibly going to be the most well-known market category. Factors such as the product's unique entry mode into the abdominal cavity during laparoscopic surgeries, its flexible usage, and its versatile applicability are driving its growth. Also, the ease of use and low risk of infection drive segments in the coming years.
The optical trocars segment is expected to register the fastest CAGR during the forecast period. Worldwide adoption of optical trocars is supported by factors like the rising number of laparoscopic surgeries performed and the ability to view tissues in detail. The benefits of this product also include the safe and quick initial placement of trocars, which is anticipated to propel the segment's growth.
In terms of application, the general surgery segment led the market with the largest revenue share in 2023. This dominance can be attributed to the increasing number of surgical procedures and demand for trocars. According to the National Center for Biotechnology Information (NCBI) report, around 330 million major surgeries were performed annually globally in 2020, around 50 million in Europe and 40 million in the U.S. Surgeons can introduce surgical instruments through cannulas inserted through these incisions made trocar.
The general surgery segment is also expected to grow at the fastest CAGR during the forecast period, owing to the increasing hospitalization of patients with cancer, heart attack, and others. Laparoscopic surgical trocars are highly functional and safe instruments precisely engineered for use during these surgeries.
North America market dominated the market with a revenue share of a 31.52% in 2023. In North America, the market is being further enhanced by rising preference for laparoscopic procedures over open procedures and increased competition among major players in terms of new product development.
The U.S. market is expected to grow the fastest CAGR during the forecast period, due to rising spending on healthcare technology and growing awareness of the advantages of laparoscopic and minimally invasive surgery among general practitioners and patients.
Europe market was identified as a lucrative region in this industry. Operative laparoscopy has become the standard and most acceptable approach for most of the common surgeries like cholecystectomy, ovarian cystectomy, ligation, appendectomy, and others in European hospitals.
The UK market is expected to grow the fastest CAGR over the forecast period, due to rising volume of surgical procedures such as bariatric surgery. According to the UK National Bariatric Surgery Registry report 2020, each year around 6 to 7 thousand primary bariatric surgeries are performed in country.
The France market is expected to grow the fastest CAGR over the forecast period due to growing number of laparoscopic surgeries related to gynecology. According to French Federation of Digestive and Visceral Surgery (FCVD), over 250,000 surgeries related to digestive system are performed through laparoscopy annually in France. Thus, increasing numbers of these surgeries is expected to boost demand for trocars in the forecast period.
The Asia Pacific market is anticipated to witness significant CAGR over the forecast period. This growth is due to the significantly increasing investments in trocars technologies across the region. Japan, China, South Korea, India, and Singapore are leading the way in promoting laparoscopic surgery adoption and fostering innovation through government-led initiatives.The Asia-Pacific trocar is likely to explore more advanced applications as advanced trocars develop.
The China market is expected to grow the fastest CAGR over the forecast period. This growth is attributed to government initiatives to support the market. For instance, the Chinese Ministry of Health is launching initiatives to train surgeons in laparoscopic surgery.
The Japan market is expected to grow fastest CAGR over the forecast period due increasing number of gastrointestinal surgeries. According to National Center for Biotechnology Information report 2021, around 3,669 laparoscopic metabolic or bariatric surgeries were performed in Japan from 2000 to 2019.
The Saudi Arabia market is expected to grow the fastest CAGR over the forecast period. Robotic and laparoscopic surgeries represent a significant advancement in the field of medical science, providing patients with minimally invasive surgery options for variety of procedure in Saudi Arabia.
The Kuwait market is expected to grow the fastest CAGR over the forecast period due to rapid development in healthcare infrastructure of cities like Kuwait City, Al Farwaniyah, Hawalli, Al Jahra, and others.
Some of the key players operating in the market include Teleflex Incorporated, Medtronic, and Johnson & Johnson Service Inc. Different strategies are taken by the players to strengthen their market position globally. Companies are involved in expanding their market presence by signing agreements with other players in emerging markets. New product approval is another strategy adopted by these players.
Emerging players like Genicon, Inc., Espiner, and Dutch Ophthalmic Research Center (International) B.V. are undertaking various strategies such as new product development and their launch, partnership, and collaboration with key participants and other players in industry to expand their presence.
The following are the leading companies in the trocars market. These companies collectively hold the largest market share and dictate industry trends. Financials, strategy maps & products of these trocars companies are analyzed to map the supply network.
In September 2022, AFS Medical GmBH launched LEXION AP 50/30, a new product in the trocar line. This product launch is expected to boost market growth
In March 2022, DORC International launched EVA NEXUS, a highly responsive infusion system for cataract surgery
In May 2021, Espiner launched the Espiner Trocar designed for precision and control, providing straightforward and safe access to the peritoneal cavity. This launch is anticipated to drive market growth
Report Attribute |
Details |
Market size value in 2024 |
USD 1.53 billion |
Revenue forecast in 2030 |
USD 2.32 billion |
Growth rate |
CAGR of 7.10% from 2024 to 2030 |
Base year for estimation |
2023 |
Historical data |
2018 - 2022 |
Forecast period |
2024 - 2030 |
Report updated |
February 2024 |
Quantitative units |
Revenue in USD million/billion and CAGR from 2024 to 2030 |
Report coverage |
Revenue forecast, company ranking, competitive landscape, growth factors, and trends |
Segments covered |
Product type, tip, application, region |
Regional scope |
North America; Europe; Asia Pacific; Latin America; MEA |
Country scope |
U.S.; Canada; UK; Germany; France; Italy; Spain; Denmark; Sweden; Norway; Japan; China; India; Australia; Thailand; South Korea; Brazil; Mexico; Argentina; South Africa; Saudi Arabia; UAE; Kuwait |
Key companies profiled |
CONMED Corporation; The Cooper Companies Inc.; Teleflex Incorporated; GENICON, INC.; Medtronic; B. Braun Medical Inc.; Johnson & Johnson Service Inc., Purple Surgical: Applied Medical Resources Corporation; LaproSurge |
Customization scope |
Free report customization (equivalent up to 8 analyst’s working days) with purchase. Addition or alteration to country, regional & segment scope. |
Pricing and purchase options |
Avail customized purchase options to meet your exact research needs. Explore purchase options |
This report forecasts revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2018 to 2030. For this report, Grand View Research has segmented the global trocars market report based on product type, tip, application, and region.
Product Type Outlook (Revenue, USD Million, 2018 - 2030)
Disposable Trocars
Reusable Trocars
Tip Outlook (Revenue, USD Million, 2018 - 2030)
Bladeless Trocars
Optical Trocars
Blunt Trocars
Bladed Trocars
Application Outlook (Revenue, USD Million, 2018 - 2030)
General Surgery
Gynecological Surgery
Urological Surgery
Pediatric Surgery
Other Surgeries
Regional Outlook (Revenue, USD Million, 2018 - 2030)
North America
U.S.
Canada
Europe
UK
Germany
France
Italy
Spain
Denmark
Sweden
Norway
Asia Pacific
China
Japan
India
South Korea
Australia
Thailand
Latin America
Brazil
Mexico
Argentina
Middle East and Africa (MEA)
South Africa
Saudi Arabia
UAE
Kuwait
b. The global trocars market size was estimated at USD 1.45 billion in 2023 and is expected to reach USD 1.54 million in 2024.
b. The global trocars market is expected to witness a compound annual growth rate of 7.10% from 2024 to 2030 to reach USD 2.32 billion by 2030.
b. North America dominated the trocars market with a market share of 45.8% in 2023. This is attributable to rising healthcare awareness and constant research and development initiatives.
b. Some key players operating in the trocars market include CONMED Corporation, The Cooper Companies Inc., Teleflex Incorporated, GENICON, INC, Medtronic, B. Braun Medical Inc., and Johnson & Johnson.
b. Key factors that are driving the market growth include increasing reliance on laparoscopy, favorable reimbursement policies, and increasing geriatric population.
NEED A CUSTOM REPORT?
We can customize every report - free of charge - including purchasing stand-alone sections or country-level reports, as well as offer affordable discounts for start-ups & universities. Contact us now
We are GDPR and CCPA compliant! Your transaction & personal information is safe and secure. For more details, please read our privacy policy.
"The quality of research they have done for us has been excellent."